Cargando…
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020
Epidermolysis bullosa (EB) is a group of rare genetic disorders for which significant progress has been achieved in the development of molecular therapies in the last few decades. Such therapies require knowledge of mutant genes and specific mutations, some of them being allele specific. A relativel...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264085/ https://www.ncbi.nlm.nih.gov/pubmed/32328988 http://dx.doi.org/10.1007/s40291-020-00466-7 |